AVLSA
Atlas Venture Life Science Advisors’s Xilio Therapeutics XLO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-992,912
| Closed | -$1.07M | – | 16 |
|
|
2024
Q1 | $1.07M | Sell |
992,912
-1,766,432
| -64% | -$1.91M | 0.1% | 15 |
|
|
2023
Q4 | $1.52M | Hold |
2,759,344
| – | – | 0.18% | 15 |
|
|
2023
Q3 | $5.82M | Hold |
2,759,344
| – | – | 0.9% | 13 |
|
|
2023
Q2 | $7.23M | Hold |
2,759,344
| – | – | 0.9% | 12 |
|
|
2023
Q1 | $8.75M | Hold |
2,759,344
| – | – | 1.18% | 12 |
|
|
2022
Q4 | $7.42M | Hold |
2,759,344
| – | – | 0.89% | 12 |
|
|
2022
Q3 | $8.03M | Hold |
2,759,344
| – | – | 0.89% | 12 |
|
|
2022
Q2 | $8.06M | Hold |
2,759,344
| – | – | 1.35% | 11 |
|
|
2022
Q1 | $19.5M | Hold |
2,759,344
| – | – | 2.47% | 10 |
|
|
2021
Q4 | $44.2M | Buy |
+2,759,344
| New | +$44.2M | 4.06% | 8 |
|